Trial of HPV vaccine completed: more effective cancer prevention
8 August 2017
A new HPV (human papilloma virus) vaccine that protects against 9 types of the virus – 7 of which cause most cases of cervical cancer – has now been fully tested in a trial co-organised by Professor Jack Cuzick.
The new vaccine offers significantly greater protection than the current vaccine, which protects against only two cancer-causing types of HPV.
Daily aspirin can reduce cancer risk
23 March 2015
